call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Drug Discovery Services Market
Inquire Before Buying Request for Sample

Drug Discovery Services Market

Home Healthcare And Pharmaceutical Drug Discovery Services Market

Drug Discovery Services Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Chemistry Services, Biology Services); By Process (Target Validation, Target Selection, Hit-To-Lead Identification, Candidate Validation, Lead Optimization); By Drug Type (Biologics, Small Molecule Drugs); By Therapeutic Area (Neurology, Infectious & Immune System Diseases, Digestive System Diseases, Oncology, Others); By End User (Pharmaceutical & Biotechnology Companies, Academic Institutes, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: June 2023
  • Report ID: BWC23487
  • Available Format: PDF
  • Page: 400

Report Overview

Increasing investments in drug R&D by pharmaceutical and biotechnology companies, advancements in technology, rising prevalence of chronic and infectious diseases, and growing outsourcing of drug discovery services are projected to propel the expansion of global drug discovery services market during the forecast period between 2023 and 2029.

Global Drug Discovery Services Market - Industry Trends & Forecast Report, 2029

Global drug discovery services market size was estimated at USD 18.5 billion in 2022. During the forecast period between 2023 and 2029, the global drug discovery services market size is projected to grow at a CAGR of 15.2% reaching a value of USD 52.8 billion by 2029. Major growth drivers for the global drug discovery services market include increasing R&D investments, the growing prevalence of chronic diseases, technological advancements, and the trend of outsourcing drug discovery services. Increasing emphasis on research and development (R&D) activities by pharmaceutical companies and biotechnology firms. These organizations are investing heavily in drug discovery to develop innovative and effective therapies. As a result, there is a growing demand for drug discovery services to streamline the drug development process, improve success rates, and reduce time and cost associated with bringing a new drug to market.

Drug Discovery Services Market

Global Drug Discovery Services Market – Overview

Drug discovery services refer to a range of specialized services offered by contract research organizations (CROs), academic institutions, and other service providers to support the drug discovery process. These services aim to accelerate and enhance the identification, optimization, and development of potential drug candidates.

The services involve the screening of large compound libraries or databases to identify hits, which are compounds that show activity against a specific disease target. These hits undergo further optimization through medicinal chemistry techniques to enhance their potency, selectivity, and other drug-like properties.

Global Drug Discovery Services Market

Growth Drivers

Increasing Prevalence of Chronic Diseases

The rising burden of chronic diseases is a global health concern. According to the World Health Organization (WHO), chronic diseases account for the majority of deaths worldwide, with an estimated 71% of all deaths attributed to non-communicable diseases (NCDs). As the global population continues to grow and age, the incidence and prevalence of chronic diseases are expected to increase further. This necessitates the development of innovative and effective drugs to address the specific needs of patients with these conditions. The limited effectiveness of existing therapies for many chronic diseases creates a need for novel treatment options. While there have been significant advancements in the management of chronic diseases, there are still unmet medical needs and areas where current treatments fall short. Drug discovery services can assist in identifying new drug candidates and optimizing their efficacy, safety, and tolerability to address these gaps in therapy.

Restraints

High Failure Rates

Drug discovery is a complex and challenging process that involves extensive research and development efforts to identify and develop effective drug candidates. However, the majority of drug candidates that enter the development pipeline fail to reach the market for various reasons. These high failure rates pose several challenges and limitations for drug discovery services. The primary reason for the high failure rates is the inability of drug candidates to demonstrate sufficient efficacy and safety profiles during preclinical and clinical testing. Many drug candidates that show promise in early-stage studies fail to produce the desired therapeutic effects or exhibit unexpected toxicity or side effects during subsequent testing phases. This necessitates early identification and mitigation of potential efficacy and safety concerns through robust preclinical and clinical evaluation, which increases the time and cost of drug development.

Impact of COVID-19 on Global Drug Discovery Services Market

The COVID-19 pandemic disrupted the research and development activities of pharmaceutical and biotech companies. Lockdown measures, travel restrictions, and social distancing guidelines led to the closure of labs, reduced productivity, and delayed timelines. This affected the drug discovery process and the overall demand for drug discovery services. The urgent need to develop effective treatments and vaccines for COVID-19 diverted significant resources and attention from other therapeutic areas. Many pharmaceutical companies and contract research organizations (CROs) shifted their focus toward COVID-19-related research, leading to a slowdown in non-COVID drug discovery projects. Despite these challenges, the COVID-19 pandemic also highlighted the importance of drug discovery and accelerated innovation in the pharmaceutical industry. The crisis spurred collaborations, increased investment in research and development, and prompted the adoption of new technologies and approaches. As the world recovers from the pandemic, the drug discovery services market is expected to rebound and grow, driven by an increasing focus on healthcare and the need for novel therapeutics.

Global Drug Discovery Services Market

Segmental Coverage

Global Drug Discovery Services Market – By Drug Type

By drug type, the global drug discovery services market is bifurcated into biologics and small molecule drugs segments. During the period in analysis, the small molecule drugs segment is expected to hold a significant market share due to the simplicity of working with small compounds, their affordability, and the rising number of start-ups and new entrants concentrating on creating small-molecule therapies.

Drug Discovery Services Market Share

Global Drug Discovery Services Market – By Therapeutic Area

Based on therapeutic area, the drug discovery services market segmented into neurology, infectious & immune system diseases, digestive system diseases, oncology, and others. During the forecast period, the oncology segment is expected to hold a significant market share. Cancer is a complex disease with diverse molecular pathways and mechanisms. This complexity necessitates extensive research and development efforts to identify and develop effective therapies. Drug discovery services play a crucial role in understanding the underlying biology of cancer, identifying potential drug targets, and conducting preclinical and clinical trials for new oncology drugs. Pharmaceutical companies, biotech firms, and academic research institutions have made substantial investments in oncology research and development. The potential for high returns on investment, coupled with the pressing need for effective cancer treatments, has led to significant funding and resources being allocated to oncology drug discovery services.

Global Drug Discovery Services Market – By End User

Based on end user, the drug discovery services market segmented into pharmaceutical & biotechnology companies, academic institutes, and others. During the period in analysis, the pharmaceutical & biotechnology companies segment is expected to hold a significant market share. These companies typically have a robust pipeline of drug candidates in various stages of development. They continuously seek to expand their product portfolios and address unmet medical needs. By leveraging drug discovery services, they can accelerate the identification, validation, and optimization of potential drug candidates, thereby maintaining a competitive edge in the market.

Global Drug Discovery Services Market – By Region

By geography, the global drug discovery services market segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Asia Pacific dominated the global drug discovery services market and is expected to continue to dominate over the forecast period. The APAC region has experienced significant growth in its pharmaceutical and biotechnology sectors. Countries like China and India have emerged as major hubs for drug discovery and development due to their large population, growing middle class, and increasing healthcare expenditures. This has fueled the demand for drug discovery services in the region.

Competitive Landscape

Major players operating in global drug discovery services market include General Electric, Eurofins Scientific, Syngene International Limited, Wuxi AppTec, Frontage Labs, Domainex, WIL Research Laboratories LLC, Shanghai Medicilon, Inc., Labcorp Drug Development, Jubilant Biosys Ltd., Evotec, Shanghai ChemPartner, Charles River Laboratories, Merck & Co. Inc., and Thermo Fisher Scientific Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In February 2023 - Pioneering Medicines, a project of Flagship Pioneering (US), and Charles River Laboratories (US), announced a multi-program agreement that will give Pioneering Medicines access to Charles River's Logica Al platform for the discovery of small-molecule pharmaceuticals.

  • In February 2023 - A multi-target integrated drug discovery agreement between Evotec SE and Related Sciences expanded their relationship. In order to address unmet patient requirements, the two businesses set out to choose, find, and create precisely tailored medications.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Billion

Market Coverage

North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, The Netherlands, Belgium, NORDIC Countries, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Philippines, Vietnam, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Peru, Colombia, Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Qatar, Kuwait, Iran, South Africa, Nigeria, Kenya, Egypt, Morocco, Algeria, Rest of Middle East & Africa)

Product/ Service Segmentation

Type, Process, Drug Type, Therapeutic Area, End User, Region

Key Players

General Electric, Eurofins Scientific, Syngene International Limited, Wuxi AppTec, Frontage Labs, Domainex, WIL Research Laboratories LLC, Shanghai Medicilon, Inc., Labcorp Drug Development, Jubilant Biosys Ltd., Evotec, Shanghai ChemPartner, Charles River Laboratories, Merck & Co. Inc., Thermo Fisher Scientific Inc.

 

     By Type

  • Chemistry Services

  • Biology Services

By Process

  • Target Validation

  • Target Selection

  • Hit-To-Lead Identification

  • Candidate Validation

  • Lead Optimization

     By Drug Type

  • Biologics

  • Small Molecule Drugs

     By Therapeutic Area

  • Neurology

  • Infectious & Immune System Diseases

  • Digestive System Diseases

  • Oncology

  • Others

     By End User

  • Pharmaceutical & Biotechnology Companies

  • Academic Institutes

  • Others

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Drug Discovery Services Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Growing prevalence of chronic diseases
        2. Outsourcing of drug discovery activities
        3. Increasing R&D expenditure
      2. Restraints
        1. Stringent regulatory requirements
        2. High failure rates
      3. Opportunities
        1. Emergence of personalized medicine
        2. Increasing focus on rare diseases and orphan drugs
      4. Challenges
        1. Ethical concerns and public perception
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    6. Global Drug Discovery Services Market Overview
    7. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    8. Market Share & Forecast
      1. By Type
        1. Chemistry Services
        2. Biology Services
      2. By Process
        1. Target Validation
        2. Target Selection
        3. Hit-To-Lead Identification
        4. Candidate Validation
        5. Lead Optimization
      3. By Drug Type
        1. Biologics
        2. Small Molecule Drugs
      4. By Therapeutic Area
        1. Neurology
        2. Infectious & Immune System Diseases
        3. Digestive System Diseases
        4. Oncology
        5. Others
      5. By End User
        1. Pharmaceutical & Biotechnology Companies
        2. Academic Institutes
        3. Others
      6. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  4. North America Drug Discovery Services Market
      1. Market Size & Forecast, 2019–2029
      2. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Process
      3. By Drug Type
      4. By Therapeutic Area
      5. By End User
      6. By Country
        1. United States
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        2. Canada
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
  5. Europe Drug Discovery Services Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Process
      3. By Drug Type
      4. By Therapeutic Area
      5. By End User
      6. By Country
        1. Germany
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        2. United Kingdom
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        3. Italy
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        4. France
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        5. Spain
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        6. Belgium
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        7. Russia
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User

 

        1. The Netherlands
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        2. Rest of Europe
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
  2. Asia-Pacific Drug Discovery Services Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Process
      3. By Drug Type
      4. By Therapeutic Area
      5. By End User
      6. By Country
        1. China
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        2. India
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        3. Japan
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        4. South Korea
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        5. Australia & New Zealand
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        6. Indonesia
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        7. Malaysia
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        8. Singapore
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        9. Vietnam
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        10. Rest of APAC
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
  3. Latin America Drug Discovery Services Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Process
      3. By Drug Type
      4. By Therapeutic Area
      5. By End User
      6. By Country
        1. Brazil
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        2. Mexico
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        3. Argentina
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        4. Peru
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        5. Rest of Latin America
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
  4.  Middle East & Africa Drug Discovery Services Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Process
      3. By Drug Type
      4. By Therapeutic Area
      5. By End User
      6. By Country
        1. Saudi Arabia
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        2. UAE
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        3. Qatar
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        4. Kuwait
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        5. South Africa
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        6. Nigeria
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        7. Algeria
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
        8. Rest of MEA
          1. By Type
          2. By Process
          3. By Drug Type
          4. By Therapeutic Area
          5. By End User
  5. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Drug Discovery Services Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
  6. Impact of Covid-19 on Global Drug Discovery Services Market
  7. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. General Electric
    2. Eurofins Scientific
    3. Syngene International Limited
    4. Wuxi AppTec
    5. Frontage Labs
    6. Domainex
    7. WIL Research Laboratories LLC
    8. Shanghai Medicilon, Inc.
    9. Labcorp Drug Development
    10. Jubilant Biosys Ltd.
    11. Evotec
    12. Shanghai ChemPartner
    13. Charles River Laboratories
    14. Merck & Co. Inc.
    15. Thermo Fisher Scientific Inc.
    16. Other Prominent Players
  8. Key Strategic Recommendations
  9. Research Methodology
    1. Qualitative Research
      1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
      1. Secondary Research
      2. Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5. Assumptions & Limitations

 

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

 

 

List of Figures

Figure 1       Global Drug Discovery Services Segmentation

Figure 2       Global Drug Discovery Services Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 5       Global Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 6       Global Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 7       Global Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 8       Global Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 9       Global Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 10     Global Drug Discovery Services Market Share, By Region, By Value, 2019–2029

Figure 11     North America Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 12     North America Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 13     North America Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 14     North America Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 15     North America Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 16     North America Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 17     North America Drug Discovery Services Market Share, By Country, By Value, 2019–2029

Figure 18     United States Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 19     United States Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 20     United States Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 21     United States Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 22     United States Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 23     United States Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 24     Canada Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 25     Canada Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 26     Canada Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 27     Canada Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 28     Canada Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 29     Canada Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 30     Europe Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 31     Europe Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 32     Europe Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 33     Europe Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 34     Europe Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 35     Europe Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 36     Europe Drug Discovery Services Market Share, By Country, By Value, 2019–2029

Figure 37     Germany Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 38     Germany Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 39     Germany Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 40     Germany Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 41     Germany Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 42     Germany Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 43     United Kingdom Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 44     United Kingdom Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 45     United Kingdom Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 46     United Kingdom Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 47     United Kingdom Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 48     United Kingdom Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 49     Italy Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 50     Italy Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 51     Italy Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 52     Italy Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 53     Italy Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 54     Italy Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 55     France Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 56     France Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 57     France Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 58     France Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 59     France Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 60     France Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 61     Spain Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 62     Spain Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 63     Spain Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 64     Spain Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 65     Spain Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 66     Spain Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 67     Belgium Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 68     Belgium Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 69     Belgium Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 70     Belgium Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 71     Belgium Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 72     Belgium Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 73     Russia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 74     Russia Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 75     Russia Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 76     Russia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 77     Russia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 78     Russia Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 79     The Netherlands Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 80     The Netherlands Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 81     The Netherlands Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 82     The Netherlands Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 83     The Netherlands Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 84     The Netherlands Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 85     Rest of Europe Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 86     Rest of Europe Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 87     Rest of Europe Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 88     Rest of Europe Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 89     Rest of Europe Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 90     Rest of Europe Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 91     Asia-Pacific Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 92     Asia-Pacific Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 93     Asia-Pacific Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 94     Asia-Pacific Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 95     Asia-Pacific Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 96     Asia-Pacific Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 97     Asia-Pacific Drug Discovery Services Market Share, By Country, By Value, 2019–2029

Figure 98     China Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 99     China Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 100   China Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 101   China Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 102   China Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 103   China Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 104   India Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 105   India Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 106   India Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 107   India Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 108   India Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 109   India Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 110   Japan Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 111   Japan Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 112   Japan Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 113   Japan Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 114   Japan Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 115   Japan Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 116   South Korea Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 117   South Korea Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 118   South Korea Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 119   South Korea Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 120   South Korea Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 121   South Korea Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 122   Australia & New Zealand Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 123   Australia & New Zealand Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 124   Australia & New Zealand Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 125   Australia & New Zealand Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 126   Australia & New Zealand Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 127   Australia & New Zealand Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 128   Indonesia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 129   Indonesia Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 130   Indonesia Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 131   Indonesia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 132   Indonesia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 133   Indonesia Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 134   Malaysia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 135   Malaysia Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 136   Malaysia Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 137   Malaysia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 138   Malaysia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 139   Malaysia Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 140   Singapore Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 141   Singapore Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 142   Singapore Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 143   Singapore Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 144   Singapore Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 145   Singapore Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 146   Vietnam Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 147   Vietnam Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 148   Vietnam Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 149   Vietnam Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 150   Vietnam Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 151   Vietnam Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 152   Rest of APAC Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 153   Rest of APAC Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 154   Rest of APAC Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 155   Rest of APAC Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 156   Rest of APAC Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 157   Rest of APAC Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 158   Latin America Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 159   Latin America Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 160   Latin America Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 161   Latin America Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 162   Latin America Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 163   Latin America Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 164   Latin America Drug Discovery Services Market Share, By Country, By Value, 2019–2029

Figure 165   Brazil Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 166   Brazil Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 167   Brazil Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 168   Brazil Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 169   Brazil Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 170   Brazil Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 171   Mexico Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 172   Mexico Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 173   Mexico Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 174   Mexico Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 175   Mexico Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 176   Mexico Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 177   Argentina Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 178   Argentina Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 179   Argentina Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 180   Argentina Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 181   Argentina Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 182   Argentina Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 183   Peru Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 184   Peru Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 185   Peru Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 186   Peru Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 187   Peru Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 188   Peru Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 189   Rest of LATAM Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 190   Rest of LATAM Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 191   Rest of LATAM Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 192   Rest of LATAM Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 193   Rest of LATAM Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 194   Rest of LATAM Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 195   Middle East & Africa Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 196   Middle East & Africa Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 197   Middle East & Africa Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 198   Middle East & Africa Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 199   Middle East & Africa Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 200   Middle East & Africa Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 201   Middle East & Africa Drug Discovery Services Market Share, By Country, By Value, 2019–2029

Figure 202   Saudi Arabia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 203   Saudi Arabia Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 204   Saudi Arabia Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 205   Saudi Arabia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 206   Saudi Arabia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 207   Saudi Arabia Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 208   UAE Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 209   UAE Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 210   UAE Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 211   UAE Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 212   UAE Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 213   UAE Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 214   Qatar Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 215   Qatar Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 216   Qatar Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 217   Qatar Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 218   Qatar Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 219   Qatar Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 220   Kuwait Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 221   Kuwait Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 222   Kuwait Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 223   Kuwait Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 224   Kuwait Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 225   Kuwait Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 226   South Africa Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 227   South Africa Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 228   South Africa Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 229   South Africa Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 230   South Africa Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 231   South Africa Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 232   Nigeria Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 233   Nigeria Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 234   Nigeria Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 235   Nigeria Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 236   Nigeria Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 237   Nigeria Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 237   Nigeria Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 238   Algeria Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 239   Algeria Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 240   Algeria Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 241   Algeria Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 242   Algeria Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 243   Algeria Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Figure 244   Rest of MEA Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Figure 245   Rest of MEA Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Figure 246   Rest of MEA Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Figure 247   Rest of MEA Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Figure 248   Rest of MEA Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Figure 249   Rest of MEA Drug Discovery Services Market Share, By End User, By Value, 2019–2029

         

List of Tables

Table 1        Global Drug Discovery Services Segmentation

Table 2        Global Drug Discovery Services Market Value Chain Analysis

Table 3        Company Market Size Analysis, 2022

Table 4        Global Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 5        Global Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 6        Global Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 7        Global Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 8        Global Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 9        Global Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 10      Global Drug Discovery Services Market Share, By Region, By Value, 2019–2029

Table 11      North America Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 12      North America Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 13      North America Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 14      North America Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 15      North America Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 16      North America Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 17      North America Drug Discovery Services Market Share, By Country, By Value, 2019–2029

Table 18      United States Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 19      United States Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 20      United States Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 21      United States Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 22      United States Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 23      United States Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 24      Canada Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 25      Canada Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 26      Canada Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 27      Canada Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 28      Canada Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 29      Canada Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 30      Europe Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 31      Europe Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 32      Europe Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 33      Europe Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 34      Europe Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 35      Europe Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 36      Europe Drug Discovery Services Market Share, By Country, By Value, 2019–2029

Table 37      Germany Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 38      Germany Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 39      Germany Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 40      Germany Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 41      Germany Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 42      Germany Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 43      United Kingdom Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 44      United Kingdom Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 45      United Kingdom Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 46      United Kingdom Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 47      United Kingdom Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 48      United Kingdom Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 49      Italy Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 50      Italy Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 51      Italy Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 52      Italy Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 53      Italy Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 54      Italy Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 55      France Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 56      France Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 57      France Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 58      France Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 59      France Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 60      France Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 61      Spain Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 62      Spain Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 63      Spain Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 64      Spain Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 65      Spain Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 66      Spain Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 67      Belgium Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 68      Belgium Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 69      Belgium Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 70      Belgium Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 71      Belgium Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 72      Belgium Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 73      Russia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 74      Russia Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 75      Russia Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 76      Russia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 77      Russia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 78      Russia Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 79      The Netherlands Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 80      The Netherlands Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 81      The Netherlands Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 82      The Netherlands Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 83      The Netherlands Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 84      The Netherlands Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 85      Rest of Europe Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 86      Rest of Europe Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 87      Rest of Europe Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 88      Rest of Europe Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 89      Rest of Europe Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 90      Rest of Europe Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 91      Asia-Pacific Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 92      Asia-Pacific Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 93      Asia-Pacific Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 94      Asia-Pacific Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 95      Asia-Pacific Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 96      Asia-Pacific Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 97      Asia-Pacific Drug Discovery Services Market Share, By Country, By Value, 2019–2029

Table 98      China Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 99      China Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 100    China Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 101    China Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 102    China Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 103    China Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 104    India Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 105    India Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 106    India Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 107    India Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 108    India Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 109    India Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 110    Japan Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 111    Japan Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 112    Japan Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 113    Japan Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 114    Japan Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 115    Japan Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 116    South Korea Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 117    South Korea Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 118    South Korea Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 119    South Korea Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 120    South Korea Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 121    South Korea Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 122    Australia & New Zealand Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 123    Australia & New Zealand Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 124    Australia & New Zealand Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 125    Australia & New Zealand Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 126    Australia & New Zealand Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 127    Australia & New Zealand Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 128    Indonesia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 129    Indonesia Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 130    Indonesia Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 131    Indonesia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 132    Indonesia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 133    Indonesia Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 134    Malaysia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 135    Malaysia Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 136    Malaysia Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 137    Malaysia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 138    Malaysia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 139    Malaysia Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 140    Singapore Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 141    Singapore Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 142    Singapore Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 143    Singapore Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 144    Singapore Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 145    Singapore Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 146    Vietnam Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 147    Vietnam Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 148    Vietnam Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 149    Vietnam Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 150    Vietnam Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 151    Vietnam Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 152    Rest of APAC Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 153    Rest of APAC Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 154    Rest of APAC Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 155    Rest of APAC Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 156    Rest of APAC Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 157    Rest of APAC Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 158    Latin America Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 159    Latin America Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 160    Latin America Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 161    Latin America Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 162    Latin America Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 163    Latin America Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 164    Latin America Drug Discovery Services Market Share, By Country, By Value, 2019–2029

Table 165    Brazil Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 166    Brazil Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 167    Brazil Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 168    Brazil Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 169    Brazil Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 170    Brazil Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 171    Mexico Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 172    Mexico Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 173    Mexico Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 174    Mexico Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 175    Mexico Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 176    Mexico Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 177    Argentina Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 178    Argentina Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 179    Argentina Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 180    Argentina Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 181    Argentina Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 182    Argentina Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 183    Peru Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 184    Peru Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 185    Peru Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 186    Peru Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 187    Peru Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 188    Peru Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 189    Rest of LATAM Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 190    Rest of LATAM Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 191    Rest of LATAM Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 192    Rest of LATAM Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 193    Rest of LATAM Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 194    Rest of LATAM Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 195    Middle East & Africa Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 196    Middle East & Africa Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 197    Middle East & Africa Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 198    Middle East & Africa Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 199    Middle East & Africa Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 200    Middle East & Africa Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 201    Middle East & Africa Drug Discovery Services Market Share, By Country, By Value, 2019–2029

Table 202    Saudi Arabia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 203    Saudi Arabia Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 204    Saudi Arabia Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 205    Saudi Arabia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 206    Saudi Arabia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 207    Saudi Arabia Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 208    UAE Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 209    UAE Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 210    UAE Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 211    UAE Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 212    UAE Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 213    UAE Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 214    Qatar Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 215    Qatar Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 216    Qatar Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 217    Qatar Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 218    Qatar Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 219    Qatar Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 220    Kuwait Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 221    Kuwait Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 222    Kuwait Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 223    Kuwait Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 224    Kuwait Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 225    Kuwait Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 226    South Africa Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 227    South Africa Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 228    South Africa Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 229    South Africa Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 230    South Africa Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 231    South Africa Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 232    Nigeria Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 233    Nigeria Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 234    Nigeria Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 235    Nigeria Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 236    Nigeria Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 237    Nigeria Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 238    Algeria Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 239    Algeria Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 240    Algeria Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 241    Algeria Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 242    Algeria Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 243    Algeria Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 244    Rest of MEA Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029

Table 245    Rest of MEA Drug Discovery Services Market Share, By Type, By Value, 2019–2029

Table 246    Rest of MEA Drug Discovery Services Market Share, By Process, By Value, 2019–2029

Table 247    Rest of MEA Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029

Table 248    Rest of MEA Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029

Table 249    Rest of MEA Drug Discovery Services Market Share, By End User, By Value, 2019–2029

Table 250    General Electric Company Overview

Table 251    General Electric Financial Overview

Table 252    Eurofins Scientific Company Overview

Table 253    Eurofins Scientific Financial Overview

Table 254    Syngene International Limited Company Overview

Table 255    Syngene International Limited Financial Overview

Table 256    Wuxi AppTec Company Overview

Table 257    Wuxi AppTec Financial Overview

Table 258    Frontage Labs Company Overview

Table 259    Frontage Labs Financial Overview

Table 260    Domainex Company Overview

Table 261    Domainex Financial Overview

Table 262    WIL Research Laboratories LLC Company Overview

Table 263    WIL Research Laboratories LLC Financial Overview

Table 264    Shanghai Medicilon, Inc. Company Overview

Table 265    Shanghai Medicilon, Inc. Financial Overview

Table 266    Labcorp Drug Development Company Overview

Table 267    Labcorp Drug Development Financial Overview

Table 268    Jubilant Biosys Ltd. Company Overview

Table 269    Jubilant Biosys Ltd. Financial Overview

Table 270    Evotec Company Overview

Table 271    Evotec Financial Overview

Table 272    Shanghai ChemPartner Company Overview

Table 273    Shanghai ChemPartner Financial Overview

Table 274    Charles River Laboratories Company Overview

Table 275    Charles River Laboratories Financial Overview

Table 276    Merck & Co. Inc. Company Overview

Table 277    Merck & Co. Inc. Financial Overview

Table 278    Thermo Fisher Scientific Inc. Company Overview

Table 279    Thermo Fisher Scientific Inc. Financial Overview     

        

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Asia Pacific holds the highest market share in the Global Drug Discovery Services Market.
Ans: In 2022, Global Drug Discovery Services Market size was estimated at USD 18.5 Billion.
Ans: Major factors driving the growth of Global Drug Discovery Services Market include growing prevalence of chronic diseases, outsourcing of drug discovery activities, and increasing R&D expenditures.
Ans: Key players in Global Drug Discovery Services Market include General Electric, Eurofins Scientific, Syngene International Limited, Wuxi AppTec, Frontage Labs, Domainex, WIL Research Laboratories LLC, Shanghai Medicilon, Inc., Labcorp Drug Development, Jubilant Biosys Ltd., Evotec, Shanghai ChemPartner, Charles River Laboratories, Merck & Co. Inc., Thermo Fisher Scientific Inc.
Ans: The chemistry services segment is expected to hold the highest market share in the Global Drug Discovery Services Market by type.